Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
PROFESSIONAL EXPERIENCE
COGENT CONSULTING INC, Winchester MA
2007 - present
Strategy consulting company focused on driving top line growth for top global and smaller pharmaceutical/biotech clients.
Completed project work in 40 countries across several therapeutic areas including oncology, immunology, diabetes,
gastroenterology, urology, hepatology, nephrology, womens health, infectious diseases, and rheumatology.
Representative projects and impact:
o Market assessment and opportunity identification for a mature respiratory product - project rolled out to 30
countries, revenues grew from $650M to over $1B during advisory work.
o Portfolio optimization for a contraception portfolio rolled out to 25 countries.
o Segmentation and opportunity prioritization for an antifungal/antimicrobial portfolio in 30+ countries.
o Go-forward/investment strategy for a mature pain product, revenues grew from $1.5B to $2B during advisory.
o Dynamic patient flow model and scenario analysis for three oncology products sold in MEA.
o Pre-launch market assessment and sizing for a new womens health product.
o Forecast platform development for pre-launch of a new antimicrobial product.
o Re-designed annual strategic planning process in Latin America (10 countries) identified and built business case
for strategic investments leading to 18% growth in year 1 and potential to double the revenue in 5 years
201.757.0393 renate.reiss@comcast.net
RENATE REISS
SCHERING-PLOUGH CORP (acquired by Merck), Kenilworth, NJ
2004 - 2006
Top 20 global pharmaceutical company with $8B in revenues in 2008 before its merger with Merck.
Developed and implemented competitive global business strategy for Hepatitis, resulting in increased overall MS in
Europe/Canada to 40% with sales increase of 9% versus prior year, a successful launch in Japan (MS 60% in year 1),
increased sales in Latin America by 36% versus prior year, and growth in Asia Pacific 55% above 2005.
Defined and promoted new structures and processes for Best in Class marketing and sales which led to significant
increase of Product Contribution and Gross Profit vs. previous year, expenses significant below vs. plan and previous
year. Major markets increased Evolution Index from 85 to 107 on average.
Created high-performance teams, achieving consensus building among diversified cultural groups. Ensured
commitment and alignment across Regional Business Teams to achieve aggressive goals.
Benchmarked, coached, and developed 100+ sales and marketing teams worldwide to enhance proficient marketing
and selling skills, piloting corporate wide initiatives.
Introduced first-ever market research to identify key influencers and KOL in the Hepatitis field resulting in a targeted
approach, KOL management plans, optimized coordination of initiatives and activities.
Orchestrated the development and implementation of 3 District Manager Coaching training courses with participants
from more than 40 countries enhancing first line management capabilities and sales force effectiveness.
2003-2004
Biotechnology and medical device company with worldwide annual sales of $130 million with 560 employees.
Reengineered unit and sales force structure optimizing resources, resulting in sales doubling within 9 months.
Designed Performance Management Assessment, tools and processes that led to higher motivation of all employees
due to clear expectations and SMART objectives. Developed and implemented a bonus system.
Conceptualized and implemented a system to monitor finance, promotional costs, and P&L in close collaboration
with Headquarters; improved reporting time by 5 business days.
Employed an action plan to achieve ambulatory procedures reimbursement for Zuidex from the Krankenkassen.
Initiated DTC activities in the RA field with a Celebrity (Lars Riedel, field track athlete).
1987 - 2003
Global pharmaceutical company with 35 000 employees and total revenue of $7.5 billion.
Developed and implemented core set of market research processes and tools to effectively monitor business and
assess impact of marketing strategy and future market opportunities.
Effectively executed Detrol Europes strategy, driving 37% year-to-year sales growth; increased product contribution
by 66% vs. previous year.
Achieved buy-in and commitment of country teams to create and implement consistent business planning process.
Conceived, planned, and led medical marketing meeting that measurably improved coordination of medical &
marketing teams. Developed framework, structure, and strategy to implement KOL management program.
Directed, rolled out and controlled implementation of key brand messages, strategy and tactics across Europe.
201.757.0393 renate.reiss@comcast.net
RENATE REISS
Pharmacia CORP, Germany, Erlangen (1987-2002)
Group Product Manager, Detrol XR, Erlangen, Germany (1998-2001)
Implemented and executed global strategy including 3 product launches, a joint venture, and a co-promotion. P&L
responsibility for 25 million and 6 million promotional costs. Managed a team of 4.
1982-1987
EDUCATION
Registered Nurse and Theatre Nurse with Diploma, Germany
Certified Project Management, Villanova University
Other
Certified Project Manager
Gold Medal for Patient Education Campaign
Silver Medal for Patient Initiative Overactive Bladder
Language: native German, fluent in English
Work permit: Europe, USA